Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Randomized Phase II Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where cisplatin-Based Treatment is Not an Option
Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation CHARM
Phase II Trial of Radium-223 Dichloride in Combination with Paclitaxel in Patients with Bone Metastatic Breast Cancer
A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without M7824 bintrafusp alfa as First-line Treatment of Biliary Tract Cancer
Phase II Trial of Response Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors
Study Type: Treatment
Phase: II
NCTID: NCT01602666
Principal Investigator:
A Phase I/II study of Bosutinib in pediatric patients with newly diagnosed chronic phase or resistant/intolerant Ph+ Chronic Myeloid Leukemia
Study Type: Treatment
Phase: I/II
NCTID: NCT04258943
Principal Investigator:
Keith August
A Multicenter Observational Study of GammaTileTM Surgically Targeted Radiation Therapy STaRT in Intracranial Brain Neoplasms
Study Type: Other
Phase: IV
NCTID: NCT04427384
Principal Investigator:
Roukoz Chamoun
A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab MSB0010718C in Combination with Other Anti-Tumor Agents as a Maintenance Treatment in Participants with Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress with First Line Platinum-Containing Chemotherapy
Study Type: Treatment
Phase: II
NCTID: NCT05327530
Principal Investigator:
Saqib Abbasi
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations A Pediatric MATCH Treatment Trial
Study Type: Treatment
Phase: II
NCTID: NCT03220035
Principal Investigator:
Kevin Ginn